1. Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
   PENG SONG et al, 2015 CrossRef
2. Establishment of a first-line second-line treatment model for human pulmonary adenocarcinoma
   Lining Wang et al, 2016 CrossRef
3. Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
   Jun-Eul Hwang et al, 2013, BMC Cancer CrossRef
4. Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells
   O. Vondálová Blanářová et al, 2013, Cell Prolif. CrossRef
5. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy
   Zheng-mao Lu et al, 2014, Tumor Biol. CrossRef
6. Cthrc1 overexpression is an independent prognostic marker in gastric cancer
   Lina Gu et al, 2014, Human Pathology CrossRef
7. The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis
   Kong-Kong Wei et al, 2014, Tumor Biol. CrossRef
8. Predictive value of excision repair cross-complementation group 1 expression for platinum-based chemotherapy and survival in gastric cancer: a meta-analysis
   Anqi Yao et al, 2014, J Cancer Res Clin Oncol CrossRef
9. Cross-reacting material 197, a heparin-binding EGF-like growth factor inhibitor, reverses the chemoresistance in human cisplatin-resistant ovarian cancer
   Xiao-han Tang et al, 2014, Anti-Cancer Drugs CrossRef
10. ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
    Grazia Palomba et al, 2014, J Transl Med CrossRef
11. Expression of XPG Protein in the Development, Progression and Prognosis of Gastric Cancer
    Na Deng et al, 2014, PLoS ONE CrossRef
12. Antiproliferative activity of rosamultic acid is associated with induction of apoptosis, cell cycle arrest, inhibition of cell migration and caspase activation in human gastric cancer (SGC-7901) cells
    Cheng-Guang Sui et al, 2015, Phytomedicine CrossRef
13. Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
    Shinya Matsuzaki et al, 2015, Cancer Cell Int CrossRef
14. Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer
    Sharareh Mokmeli et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
15. Pt(II) and Pd(II) complexes with a thiazoline derivative ligand: Synthesis, structural characterization, antiproliferative activity and evaluation of pro-apoptotic ability in tumor cell lines HT-29 and U-937
    Elena Fernández-Delgado et al, 2019, Journal of Inorganic Biochemistry CrossRef
16. ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance
    Jan Dominik Kuhlmann et al, 2014 CrossRef
17. How Prognostic and Predictive Biomarkers Are Transforming Our Understanding and Management of Advanced Gastric Cancer
    Christina Kim et al, 2014, The Oncologist CrossRef
18. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer
    Issam Chebouti et al, 2017, Oncotarget CrossRef
19. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
    Dan Gao et al, 2016, Oncotarget CrossRef
20. Altered DNA repair creates novel Alu/Alu repeat‐mediated deletions
    Maria E. Morales et al, 2021, Human Mutation CrossRef
21. A newly established monoclonal antibody against ERCC1 detects major isoforms of ERCC1 in gastric cancer
    Takayuki Oishi et al, 2021, GHM CrossRef
22. MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway
    Yannan Qin et al, 2022, Cancer Cell Int CrossRef
23. H3K27 acetylation activated‐CD109 evokes 5‐fluorouracil resistance in gastric cancer via the JNK/MAPK signaling pathway
    Fei Zhou et al, 2023, Environmental Toxicology CrossRef